Dorm Room — 2019 Investments
5 investments dated 2019 · listed companies and verified rows first · show all
Leuko develops a noninvasive white blood cell monitor to track neutropenia risk in cancer patients and others undergoing treatment.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Carlos Castro Gonzalez(Chief Executive Officer)inIan Butterworth(Chief Technology Officer)inAurelien Bourquard(Chief Data Scientist)inAlvaro Sanchez-Ferro(Chief Medical Officer)inPaul Hartung(Director)in
BoardAmy Salzhauer(Director)in
Co-investorsGood Growth CapitalMassVentures
MaestroQA offers a conversation data platform that analyzes customer interactions across calls, chat, and bots to support quality assurance and voice-of-customer programs.
AI & Machine LearningEnterprise SoftwareSaaSNew York, US
Srinivas Prathipati(Executive Officer, Director)Harrison Hunter(Director)in
BoardNihal Mehta(Director)in
Co-investorsBase10 PartnersEniac Ventures
Wilmington, US
Oluwatoniloba Oloko(Executive Officer, Director)Daniel Hanover(Executive Officer, Director)
Ballston Spa, US
Angelo Damiano(Chief Executive Officer, Secretary and Director)
BoardAlex Tellez(Director)Michael Gursha(Director)
Co-investorsTBD Angels
Vienna, US
Brian Ballard(Executive Officer, Director)inChris Hoyt(Executive Officer)in
BoardPeter Barris(Director)John Keeling(Director)Dayna Grayson(Director)Craig Cummings(Director)
Co-investorsLDV CapitalMotley Fool VenturesCiscoGE VenturesNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.